Journal
CURRENT OPINION IN BIOTECHNOLOGY
Volume 32, Issue -, Pages 21-27Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2014.10.006
Keywords
-
Funding
- ERC starting Grant (European Research Council) [336452-ENICMO]
- Fonds de la recherche scientifique, Belgium [T0.138.14]
Ask authors/readers for more resources
Various studies have described the beneficial effects of specific bacteria on the characteristics of metabolic syndrome. Intestinal microbiota might therefore represent a modifiable trait for translational intervention to improve the metabolic profiles of obese and type 2 diabetic patients. However, identifying potential probiotic strains that can effectively colonize the gastrointestinal tract and significantly affect host metabolism has been challenging. This review aims to summarize the notable advances and contributions in the field that may prove useful for identifying next-generation probiotics that target metabolic syndrome and its related disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available